Recent survival trends in diffuse large B‐cell lymphoma––Have we made any progress beyond rituximab?

by Narendranath Epperla, John L. Vaughn, Megan Othus, Abrahao Hallack, Luciano J. Costa
Published 2020-08-01

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

by Shailender Bhatia, James Moon, Kim A Margolin, Jeffrey S Weber, Christopher D Lao, Megan Othus, Ana M Aparicio, Antoni Ribas, Vernon K Sondak
Published 2012-01-01

Regimen‐intensity per count‐recovery and hospitalization index: A new tool to assign regimen intensity for AML

by Mohamed L. Sorror, Shirali Agarwal, Megan Othus, Ylinne Lynch, Jennifer E. Nyland, Mary‐Elizabeth Percival, Pamela S. Becker, Frederick R. Appelbaum, Elihu H. Estey
Published 2020-09-01

270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort

by Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Megan Othus, Sandip Patel, Sarah Fenton, Cristina Rodriguez, Adedayo Onitilo, Ahmad Mattour, Igor Rybkin, Jourdain Hayward, Christine McLeod, Helen Chen, Edward Mayerson, Christopher Ryan, Melissa Plets, Charles Blanke
Published 2020-11-01

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Trans...

by Linde M. Morsink, Brenda M. Sandmaier, Megan Othus, Raffaele Palmieri, Noa Granot, Evandro D. Bezerra, Brent L. Wood, Marco Mielcarek, Gary Schoch, Chris Davis, Mary E. D. Flowers, H. Joachim Deeg, Frederick R. Appelbaum, Rainer Storb, Roland B. Walter
Published 2020-08-01

795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blocka...

by Michael Wagner, Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Megan Othus, Sandip Patel, Edward Mayerson, Christopher Ryan, Melissa Plets, Charles Blanke, Ashish Sangal, Benjamin Powers, George Budd, Adrienne Victor, Chung-Tsen Hsueh, Rashmi Chugh, Suresh Nair, Kirsten Leu, Mark Agulnik
Published 2020-11-01

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report

by Era L. Pogosova-Agadjanyan, Anna Moseley, Megan Othus, Frederick R. Appelbaum, Thomas R. Chauncey, I-Ming L. Chen, Harry P. Erba, John E. Godwin, Isaac C. Jenkins, Min Fang, Mike Huynh, Kenneth J. Kopecky, Alan F. List, Jasmine Naru, Jerald P. Radich, Emily Stevens, Brooke E. Willborg, Cheryl L. Willman, Brent L. Wood, Qing Zhang, Soheil Meshinchi, Derek L. Stirewalt
Published 2020-08-01